Remdesivir in a pregnant patient with COVID-19 pneumonia

• Main Authors: Ranadheer Dande (Author), Anum Qureshi (Author), Kia Persaud (Author), Chahat Puri (Author), Sajida Zulfiqar (Author), Shankar Awasthi (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...